rs10958409
From SNPedia
| rs10958409 associated with increased risk of developing intracranial aneurysm. |
| Orientation | plus |
| Stabilized | plus |
| Geno | Mag | Summary |
|---|---|---|
| (A;A) | 1.79x increased aneurysm risk | |
| (A;G) | 1.37x increased aneurysm risk | |
| (G;G) | 0 | normal |
| Reference | GRCh38 38.1/141 |
| Chromosome | 8 |
| Position | 54414531 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs10958409 |
| dbSNP (classic) | rs10958409 |
| ClinGen | rs10958409 |
| ebi | rs10958409 |
| HLI | rs10958409 |
| Exac | rs10958409 |
| Gnomad | rs10958409 |
| Varsome | rs10958409 |
| LitVar | rs10958409 |
| Map | rs10958409 |
| PheGenI | rs10958409 |
| Biobank | rs10958409 |
| 1000 genomes | rs10958409 |
| hgdp | rs10958409 |
| ensembl | rs10958409 |
| geneview | rs10958409 |
| scholar | rs10958409 |
| rs10958409 | |
| pharmgkb | rs10958409 |
| gwascentral | rs10958409 |
| openSNP | rs10958409 |
| 23andMe | rs10958409 |
| SNPshot | rs10958409 |
| SNPdbe | rs10958409 |
| MSV3d | rs10958409 |
| GWAS Ctlg | rs10958409 |
| GMAF | 0.2163 |
| Max Magnitude | 0 |
| ? | (A;A) (A;G) (G;G) | 28 |
|---|---|---|
|
| ||
- rs700651 2 G 1.18x risk 1.56x risk
- rs10958409 8 A 1.37x risk 1.79x risk
- rs1333040 9 T 1.29x risk 1.67x risk
| GWAS snp | |
|---|---|
| PMID | [PMID 18997786 |
| Trait | Intracranial aneurysm |
| Title | Susceptibility loci for intracranial aneurysm in European and Japanese populations |
| Risk Allele | A |
| P-val | 1E-10 |
| Odds Ratio | 1.36 [1.24-1.49] |
[PMID 20190001
] The Relationship Between Smoking and Replicated Sequence Variants on Chromosomes 8 and 9 With Familial Intracranial Aneurysm
[PMID 20395613] Confirmation of an association of single-nucleotide polymorphism rs1333040 on 9p21 with familial and sporadic intracranial aneurysms in Japanese patients.
[PMID 22476622] Increased risk of stroke in oral contraceptive users carried replicated genetic variants: a population-based case-control study in China.
[PMID 23733552
] Genetic risk factors for intracranial aneurysms: a meta-analysis in more than 116,000 individuals.
